Clearside Biomedical Inc
NASDAQ:CLSD
Clearside Biomedical Inc
NASDAQ:CLSD
Price:
1.33 USD
1.53%
Updated:
May 21, 2024
Clearside Biomedical Inc
Total Other Income
|
Clearside Biomedical Inc
Total Other Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
Total Other Income
-$11.1m
|
CAGR 3-Years
-281%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is Clearside Biomedical Inc's Total Other Income?
Total Other Income
-11.1m
USD
-11.1m
USD
Based on the financial report for Mar 31, 2024, Clearside Biomedical Inc's Total Other Income amounts to -11.1m USD.
What is Clearside Biomedical Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
-281%
-281%
Over the last year, the Total Other Income growth was -101%. The average annual Total Other Income growth rates for Clearside Biomedical Inc have been -281% over the past three years .
You don't have any saved screeners yet
